Two-year effect of semaglutide 2.4 mg vs placebo in adults with overweight or obesity: STEP 5

M Bhatta, S Buscemi, J Frias, GMF Rigas - Obesity, 2021 - search.proquest.com
Background: The 2-year efficacy and safety of once-weekly (OW) subcutaneous semaglutide
2.4 mg vs placebo in adults with overweight/obesity was assessed in the STEP 5 phase 3 …
被引用次数：20 相关文章

Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP 5

W Garvey, R Batterham, M Bhatta, S Buscemi… - OBESITY, 2021 - iris.unipa.it
Two-year Effect of Semaglutide 2.4 mg vs Placebo in Adults with Overweight or Obesity: STEP
5 IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Data di pubblicazione …